- About SAM
- EU Council presidency
- Human medicines
- Marketing authorisation
- Drug information
- Clinical trials
- European Pharmacopoeia
- Pharmacovigilance
- Classification of medicinal products
- Statistics
- Manufacture, distribution, pharmacy
- Travelling with medicinal products
- The import and export of goods that require a special authorization
- Sending of medicinal products
- Advertising
- Marketing authorisation
- Veterinary medicines
- Department of Biologicals
- Blood handling
- Procurement and handling of cells, tissues and organs
- Biovigilance
- Application of cells, tissues and organs licence
- List of licensed procurers and handlers of cells, tissues and organs (tissue establishments)
- Legislation for procurement and handling cells, tissues and organs
- Special authorisation for import and export and notification of import and export of cells, tissues and organs
- Advanced therapies medicinal products
- The import and export of goods that require a special authorisation
- Legislation
- Supervision
- Laboratory
Main Activities of HMA
05.06.2017
The HMA:
- addresses key strategic issues for the network, such as exchange of information, IT developments and sharing of best practices
- focuses on the development, co-ordination and consistency of the European Medicines Regulatory System
- ensures the most effective and efficient use of resources across the network. This includes developing and overseeing arrangements for work-sharing
- co-ordinates the mutual recognition (MRP) and decentralised procedures (DCP).
Member agencies support the network by providing high-quality professional and scientific resources to all areas of medicines regulation including centralised, MRP, DCP and national procedures.
State Agency of Medicines
